HIM
WGS icon

Hillsdale Investment Management’s GeneDx Holdings WGS Stock Holding History

Hillsdale Investment Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-70
Closed -$7.54K – 768
2025
Q3 		$7.54K Hold
70
– – ﹤0.01% 585
2025
Q2 		$6.46K Hold
70
– – ﹤0.01% 571
2025
Q1 		$6.2K Buy
+70
New +$6.07K ﹤0.01% 548

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hillsdale Investment Management's WGS Position: Q4 2025 in Review

Hillsdale Investment Management sold out of GeneDx Holdings (WGS) in Q4 2025, closing a stake of 70 shares — an estimated $7.54K sold.

Hillsdale Investment Management first reported a position in WGS in Q1 2025 and held it in 3 quarters. The position peaked at $7.54K in Q3 2025. 286 funds tracked by Wall St. Rank hold WGS as of Q4 2025.

  • Hillsdale Investment Management reported no remaining GeneDx Holdings position as of Q4 2025 after selling out during the quarter.
  • Hillsdale Investment Management sold 70 GeneDx Holdings shares in Q4 2025, an estimated $7.54K.
  • Hillsdale Investment Management first reported a position in GeneDx Holdings in Q1 2025 and held it in 3 quarters.
  • Hillsdale Investment Management's GeneDx Holdings position peaked at $7.54K in Q3 2025.
  • 286 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2025.

Based on Hillsdale Investment Management's 13F filing for Q4 2025, filed 10 Feb 2026.